Antiphospholipid Syndrome
📧 Sign up to get email alerts when something new happens for Antiphospholipid Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE [Phase 4]
This Phase 4 clinical trial update describes a study comparing clopidogrel-based antiplatelet therapy versus warfarin for secondary preventi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study [Phase 2]
Phase 2 randomized trial to evaluate the safety and efficacy of sirolimus in primary antiphospholipid syndrome; the study is currently not r…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
A clinical trial in China recruiting to study antiphospholipid syndrome through collaborative networks.
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant [NA]
A completed clinical trial evaluated the impact of injectable anticoagulants on research involving a circulating lupus-type anticoagulant in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This clinical trial update covers the safety and potential efficacy of anti-CD19 CAR-T cells for relapsed/refractory autoimmune diseases, wi…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
A clinical trial is ongoing to study antiphospholipid syndrome in pregnancy and its potential postpartum pulmonary hypertension effects; the…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome [Phase 2]
Phase 2 clinical trial update for rivaroxaban in stroke patients with antiphospholipid syndrome and related autoimmune conditions.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Use of Warfarin After the First Trimester in Pregnant Women With APS [Phase 4]
Phase 4 trial updating use of warfarin after the first trimester in pregnant women with antiphospholipid syndrome and recurrent miscarriage.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome [Phase 4]
Phase 4 clinical trial update evaluating apixaban for secondary prevention of thromboembolism in patients with antiphospholipid syndrome has…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: The BeLimumab Antiphospholipid Syndrome Trial (BLAST) [Phase 2, Phase 3]
Clinical trial update for the BeLimumab antiphospholipid syndrome study (BLAST) covering Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients [Phase 3]
A Phase 3 trial evaluating hydroxychloroquine for primary thrombosis prevention in antiphospholipid antibody–positive patients was terminate…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome [Phase 4]
Phase 4 clinical trial investigating hydroxychloroquine sulfate for recurrent spontaneous abortion associated with antiphospholipid syndrome…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome [Phase 3]
Phase 3 trial evaluating hydroxychloroquine versus placebo for prevention of thrombotic relapse in primary antiphospholipid syndrome.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Rivaroxaban for Patients With Antiphospholipid Syndrome [Phase 3]
A Phase 3 clinical trial evaluating rivaroxaban for antiphospholipid syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients [Phase 2]
This update reports results from a Phase 2 clinical trial evaluating the effects of fluvastatin on proinflammatory and prothrombotic markers…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Rivaroxaban in Thrombotic Antiphospholipid Syndrome [Phase 3]
Phase 3 trial update for rivaroxaban in antiphospholipid syndrome; study terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Timing of Initiation of LMWH Administration in Pregnant Women With APS [Phase 4]
Phase 4 trial update on the optimal timing to initiate low molecular weight heparin in pregnant women with antiphospholipid syndrome. The co…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome [Phase 2]
A Phase 2 pilot trial evaluated Rituximab for anticoagulation-resistant manifestations of antiphospholipid syndrome; results from the comple…
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Measurement of Anti-dsDNA by Both CLIFT & ELISA [NA]
A clinical trial update from Assiut University describes evaluating measurement of anti-dsDNA using CLIFT and ELISA in antiphospholipid synd…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome [Phase 2]
Phase IIa trial of ALXN1007 for non-criteria manifestations of antiphospholipid syndrome was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
This completed trial assessed whether hydroxychloroquine affects AnxA5 resistance in antiphospholipid antibody–positive patients, with and w…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
This clinical trial update reports pharmacokinetic data for low molecular weight heparin and unfractionated heparin in pregnant participants…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients
This release reports the completion of a clinical trial evaluating the CoaguChek XS device in patients with antiphospholipid syndrome.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
A clinical trial update reporting the completion of a study on monitoring anticoagulant therapy in antiphospholipid syndrome.